BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9036566)

  • 1. [Immunoprevention of Type I diabetes mellitus].
    Spinas GA
    Ther Umsch; 1996 Dec; 53(12):882-8. PubMed ID: 9036566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug insight: New immunomodulatory therapies in type 1 diabetes.
    Cernea S; Herold KC
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):89-98. PubMed ID: 16932263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can insulin therapy delay or prevent insulin-dependent diabetes mellitus?
    Kakka R; Koda-Kimble MA
    Pharmacotherapy; 1997; 17(1):38-44. PubMed ID: 9017764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and prevention of type 1 diabetes: progress, problems, and prospects.
    Skyler JS
    Clin Pharmacol Ther; 2007 May; 81(5):768-71. PubMed ID: 17392722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials. Diabetes' brave new world.
    Couzin J
    Science; 2003 Jun; 300(5627):1862-5. PubMed ID: 12817117
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppression in Type I diabetes mellitus].
    Schönle EJ; Sizonenko PC; Spinas GA
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1225-7. PubMed ID: 2237051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to prevent type 1 diabetes.
    Thrower SL; Bingley PJ
    Diabetes Obes Metab; 2009 Oct; 11(10):931-8. PubMed ID: 19476469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is insulin-dependent diabetes mellitus a preventable disease?
    Maclaren NK; Riley WJ; Winter WE; Silverstein JH
    Clin Invest Med; 1987 Sep; 10(5):444-9. PubMed ID: 3315366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prevention of insulin-dependent diabetes mellitus].
    Loureiro MM; Duarte R; Boavida JM; Lisboa PE
    Acta Med Port; 1996; 9(10-12):353-60. PubMed ID: 9254534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects, toxicology and clinical experiences. ENDIT Group].
    Reimers JI; Andersen HU; Pociot F
    Ugeskr Laeger; 1994 Jan; 156(4):461-5. PubMed ID: 8140661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-specific tolerance in diabetes.
    Gottlieb PA; Eisenbarth GS
    Clin Immunol; 2002 Jan; 102(1):2-11. PubMed ID: 11781061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the immunointervention of type-1 diabetes mellitus.
    Schernthaner G
    Horm Metab Res; 1995 Dec; 27(12):547-54. PubMed ID: 8750784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is induction of oral tolerance to to insulin a suitable treatment concept in therapy of type I diabetes mellitus?].
    Marth T; Stallmach A
    Z Gastroenterol; 2001 May; 39(5):437-9. PubMed ID: 11413918
    [No Abstract]   [Full Text] [Related]  

  • 14. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
    Morrison EY; Ragoobirsingh D; Peter SA
    Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pre-diabetes type 1. Evaluation of current clinical trials].
    Thivolet C
    Journ Annu Diabetol Hotel Dieu; 1997; ():201-5. PubMed ID: 9296975
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacotherapies for type 1 diabetes mellitus].
    Maruyama T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():190-5. PubMed ID: 12386992
    [No Abstract]   [Full Text] [Related]  

  • 17. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.
    Simmons K; Michels AW
    Rheum Dis Clin North Am; 2014 Nov; 40(4):797-811. PubMed ID: 25437293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of oral insulin on the development of autoimmune diabetes in NOD mice fed a hypoallergenic diet.
    Shehadeh N; Weis R; Teninboum G; Benderly A; Etzioni A; Shamir R
    Diabetes Nutr Metab; 2004 Feb; 17(1):1-5. PubMed ID: 15163117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.